Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-24 @ 4:42 PM
NCT ID: NCT01917266
Eligibility Criteria: Inclusion Criteria: * Be scheduled to undergo implant of a Cardiac Resynchronization Therapy (CRT) system with approved standard indication per accepted guidelines as a new implant or an upgrade from an existing Implantable Cardioverter Defibrillator (ICD) or pacemaker with no prior left ventricular lead placement * Be in sinus rhythm at the time of enrollment * Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigational Plan described evaluations Exclusion Criteria: * Have persistent or permanent atrial fibrillation * Be in New York Heart Association (NYHA) IV functional class * Have prior left ventricular (LV) lead implant * Be pacemaker-dependent * Have a recent myocardial infarction within 40 days prior to enrollment * Have undergone cardiac bypass surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 7 months * Have had a recent Cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 3 months prior to enrollment * Have had intravenous inotropic support in the last 30 days * Exhibit Cheyne-Stokes respiration * Be less than 18 years of age * Be pregnant or planning to become pregnant during the duration of the investigation * Be currently participating in any other clinical investigation
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT01917266
Study Brief:
Protocol Section: NCT01917266